Which heart test schedule is best for breast cancer patients?
NCT ID NCT02696707
First seen Jan 11, 2026 · Last updated May 15, 2026 · Updated 22 times
Summary
This study looked at 200 early-stage breast cancer patients receiving trastuzumab, a drug that can rarely cause heart damage. Researchers compared two standard schedules for monitoring heart function to see which works better. The goal was to find the safest and most effective way to check for heart problems during treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Southlake Regional Health Centre
Newmarket, Ontario, L3Y 2P9, Canada
-
The Ottawa Hospital
Ottawa, Ontario, K1H 8L6, Canada
-
The Ottawa Hospital Cancer Centre
Ottawa, Ontario, K2H 8L6, Canada
-
Thunder Bay Regional Health Sciences Centre
Thunder Bay, Ontario, P7B 6V4, Canada
Conditions
Explore the condition pages connected to this study.